154 related articles for article (PubMed ID: 38256555)
1. Enhancing Patient Selection in Stage IIIA-IIIB NSCLC: Invasive Lymph Node Restaging after Neoadjuvant Therapy.
Kwiatkowski R; Zieliński M; Paluch J; Gabor J; Swinarew A
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256555
[TBL] [Abstract][Full Text] [Related]
2. Comparison of endobronchial ultrasound and/or endoesophageal ultrasound with transcervical extended mediastinal lymphadenectomy for staging and restaging of non-small-cell lung cancer.
Zielinski M; Szlubowski A; Kołodziej M; Orzechowski S; Laczynska E; Pankowski J; Jakubiak M; Obrochta A
J Thorac Oncol; 2013 May; 8(5):630-6. PubMed ID: 23584295
[TBL] [Abstract][Full Text] [Related]
3. Transcervical extended mediastinal lymphadenectomy for mediastinal restaging after induction therapy.
Gwóźdź P; Zieliński M
Mediastinum; 2019; 3():40. PubMed ID: 35118266
[TBL] [Abstract][Full Text] [Related]
4. Accurate and safe mediastinal restaging by combined endobronchial and endoscopic ultrasound-guided needle aspiration performed by single ultrasound bronchoscope.
Szlubowski A; Zieliński M; Soja J; Filarecka A; Orzechowski S; Pankowski J; Obrochta A; Jakubiak M; Węgrzyn J; Cmiel A
Eur J Cardiothorac Surg; 2014 Aug; 46(2):262-6. PubMed ID: 24420366
[TBL] [Abstract][Full Text] [Related]
5. Endobronchial ultrasound-guided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy--a prospective study.
Szlubowski A; Herth FJ; Soja J; Kołodziej M; Figura J; Cmiel A; Obrochta A; Pankowski J
Eur J Cardiothorac Surg; 2010 May; 37(5):1180-4. PubMed ID: 20022759
[TBL] [Abstract][Full Text] [Related]
6. Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot Experience.
Genestreti G; Burgio MA; Matteucci F; Piciucchi S; Scarpi E; Monti M; Bucchi L; Parisi E; Crociani L; Gurioli C; Poletti V; Gavelli G
Technol Cancer Res Treat; 2015 Dec; 14(6):721-7. PubMed ID: 24945370
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy.
Nasir BS; Bryant AS; Minnich DJ; Wei B; Dransfield MT; Cerfolio RJ
Ann Thorac Surg; 2014 Sep; 98(3):1008-12. PubMed ID: 25069682
[TBL] [Abstract][Full Text] [Related]
8. Is endobronchial ultrasound-guided transbronchial needle aspiration an effective diagnostic procedure in restaging of non-small cell lung cancer patients?
Cetinkaya E; Usluer O; Yılmaz A; Tutar N; Çam E; Özgül MA; Demirci NY
Endosc Ultrasound; 2017; 6(3):162-167. PubMed ID: 28621292
[TBL] [Abstract][Full Text] [Related]
9. Transcervical Extended Mediastinal Lymphadenectomy: Experience From a North American Cancer Center.
Yendamuri S; Battoo A; Dy G; Chen H; Gomez J; Singh AK; Hennon M; Nwogu CE; Dexter EU; Huang M; Picone A; Demmy TL
Ann Thorac Surg; 2017 Nov; 104(5):1644-1649. PubMed ID: 28942077
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal restaging: EUS-FNA offers a new perspective.
Annema JT; Veseliç M; Versteegh MI; Willems LN; Rabe KF
Lung Cancer; 2003 Dec; 42(3):311-8. PubMed ID: 14644519
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
Ryu JS; Choi NC; Fischman AJ; Lynch TJ; Mathisen DJ
Lung Cancer; 2002 Feb; 35(2):179-87. PubMed ID: 11804691
[TBL] [Abstract][Full Text] [Related]
12. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
13. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis.
Xu YP; Li B; Xu XL; Mao WM
Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306
[TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
Kremer R; Peysakhovich Y; Dan LF; Guralnik L; Kagna O; Nir RR; Bar-Shalom R
Ann Nucl Med; 2016 Feb; 30(2):114-21. PubMed ID: 26613715
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
16. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
[TBL] [Abstract][Full Text] [Related]
17. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
18. Transesophageal ultrasound-guided fine-needle aspiration for the mediastinal restaging of non-small cell lung cancer.
von Bartheld MB; Versteegh MI; Braun J; Willems LN; Rabe KF; Annema JT
J Thorac Oncol; 2011 Sep; 6(9):1510-5. PubMed ID: 21642873
[TBL] [Abstract][Full Text] [Related]
19. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
[TBL] [Abstract][Full Text] [Related]
20. The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA).
Heineman DJ; Beck N; Wouters MW; van Brakel TJ; Daniels JM; Schreurs WH; Dickhoff C
Eur J Surg Oncol; 2018 Jun; 44(6):830-834. PubMed ID: 29396329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
